Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin β conjugate

Endocrine-Related Cancer

Volumn 15, Issue 2, 2008, Pages 635-648

  Vuorenoja, Susanna ^a   Rivero Müller, Adolfo ^a   Ziecik, Adam J ^b   Huhtaniemi, Ilpo ^a,c   Toppari, Jorma ^a   Rahman, Nafis A ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CORTICOSTERONE; INHIBIN A; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 4; VIRUS T ANTIGEN;

ADRENAL CORTEX TUMOR; ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; DRUG TARGETING; FEMALE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SEX DIFFERENCE; SIMIAN VIRUS 40; THERAPY EFFECT; TRANSGENIC MOUSE; TREATMENT DURATION; TREATMENT RESPONSE; WESTERN BLOTTING; WILD TYPE;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DISEASE MODELS, ANIMAL; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; LUTEINIZING HORMONE; MALE; MELITTEN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, LH; RNA, MESSENGER;

EID: 45849147398     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0015     Document Type: Article

References (74)

1. Ahlman H, Khorram-Manesh A, Jansson S, Wangberg B, Nilsson O, Jacobsson CE & Lindstedt S 2001 Cytotoxic treatment of adrenocortical carcinoma. World Journal of Surgery 25 927-933.
2. Alevizaki M, Saltiki K, Mantzou E, Anastasiou E & Huhtaniemi I 2006 The adrenal gland may be a target of LH action in postmenopausal women. European Journal of Endocrinology 154 875-881.
3. Arceci RJ, King AA, Simon MC, Orkin SH & Wilson DB 1993 Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Molecular and Cellular Biology 13 2235-2246.
4. Barbosa AS, Giacaglia LR, Martin RM, Mendonca BB & Lin CJ 2004 Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms. BMC Endocrine Disorder 4 3.
5. Bielinska M, Genova E, Boime I, Parviainen H, Kiiveri S, Leppaluoto J, Rahman N, Heikinheimo M & Wilson DB 2005 Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice. Endocrinology 146 3975-3984.
6. Bielinska M, Parviainen H, Porter-Tinge SB, Kiiveri S, Genova E, Rahman N, Huhtaniemi IT, Muglia LJ, Heikinheimo M & Wilson DB 2003 Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor. Endocrinology 144 4123-4133.
7. Bodek G, Rahman NA, Zaleska M, Soliymani R, Lankinen H, Hansel W, Huhtaniemi I & Ziecik AJ 2003 A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGβ conjugate. Breast Cancer Research and Treatment 79 1-10.
8. Bodek G, Kowalczyk A, Waclawik A, Huhtaniemi I & Ziecik AJ 2005a Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGβ conjugate: functional characteristic and molecular mechanism of cell death pathway. Experimental Biology and Medicine 230 421-428.
9. Bodek G, Vierre S, Rivero-Muller A, Huhtaniemi I, Ziecik AJ & Rahman NA 2005b A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice. Neoplasia 7 497-508.
10. Bornstein SR, Stratakis CA & Chrousos GP 1999 Adrenocortical tumors: recent advances in basic concepts and clinical management. Annals of Internal Medicine 130 759-771.
11. Bourdeau I, D'Amour P, Hamet P, Boutin JM & Lacroix A 2001 Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 86 5534-5540.
12. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA & Fink G 1977 Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 269 338-340.
13. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
14. El-Hefnawy T & Huhtaniemi I 1998 Progesterone can participate in down-regulation of the luteinizing hormone receptor gene expression and function in cultured murine Leydig cells. Molecular and Cellular Endocrinology 137 127-138.
15. El-Hefnawy T, Manna PR, Luconi M, Baldi E, Slotte JP & Huhtaniemi I 2000 Progesterone action in a murine Leydig tumor cell line (mLTC-1), possibly through a nonclassical receptor type. Endocrinology 141 247-255.
16. Feelders RA, Lamberts SW, Hofland LJ, van Koetsveld PM, Verhoef-Post M, Themmen AP, de Jong FH, Bonjer HJ, Clark AJ, van der Lely AJ et al. 2003 Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. Journal of Clinical Endocrinology and Metabolism 88 230-237.
17. Gawronska B, Leuschner C, Enright FM & Hansel W 2002 Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo. Gynecologic Oncology 85 45-52.
18. Givens JR, Andersen RN, Wiser WL, Donelson AJ & Coleman SA 1975 A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism 41 845-853.
19. Goodarzi MO, Dawson DW, Li X, Lei Z, Shintaku P, Rao CV & Van Herle AJ 2003 Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. Journal of Clinical Endocrinology and Metabolism 88 73-77.
20. Haavisto AM, Pettersson K, Bergendahl M, Perheentupa A, Roser JF & Huhtaniemi I 1993 A supersensitive immunofluorometric assay for rat luteinizing hormone. Endocrinology 132 1687-1691.
21. Hanahan D 1989 Transgenic mice as probes into complex systems. Science 246 1265-1275.
22. Jaffe RB, Seron-Ferre M, Crickard K, Koritnik D, Mitchell BF & Huhtaniemi IT 1981 Regulation and function of fhe primate fetal adrenal gland and gonad. Recent Progress in Hormone Research 37 41-103.
23. Kananen K, Markkula M, Rainio E, Su JG, Hsueh AJ & Huhtaniemi IT 1995 Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines. Molecular Endocrinology 9 616-627.
24. Kananen K, Markkula M, Mikola M, Rainio EM, McNeilly A & Huhtaniemi I 1996a Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha- subunit gene. Molecular Endocrinology 10 1667-1677.
25. Kananen K, Markkula M, El-Hefnawy T, Zhang FP, Paukku T, Su JG, Hsueh AJ & Huhtaniemi I 1996b The mouse inhibin alpha-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic mice. Molecular and Cellular Endocrinology 119 135-146.
26. Kananen K, Rilianawati, Paukku T, Markkula M, Rainio EM & Huhtanemi I 1997 Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Endocrinology 138 3521-3531.
27. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, Keri RA & Huhtaniemi IT 2000 Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. Journal of Clinical Investigation 105 633-641.
28. Ketola I, Rahman N, Toppari J, Bielinska M, Porter-Tinge SB, Tapanainen JS, Huhtaniemi IT, Wilson DB & Heikinheimo M 1999 Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology 140 1470-1480.
29. Kiiveri S, Siltanen S, Rahman N, Bielinska M, Lehto VP, Huhtaniemi IT, Muglia LJ, Wilson DB & Heikinheimo M 1999 Reciprocal changes in the expression of transcription factors GATA-4 and GATA-6 accompany adrenocortical tumorigenesis in mice and humans. Molecular Medicine 5 490-501.
30. Kiiveri S, Liu J, Westerholm-Ormio M, Narita N, Wilson DB, Voutilainen R & Heikinheimo M 2002 Transcription factors GATA-4 and GATA-6 during mouse and human adrenocortical development. Endocrine Research 28 647-650.
31. Lacroix A, Hamet P & Boutin JM 1999 Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. New England Journal of Medicine 341 1577-1581.
32. de Lange WE, Pratt JJ & Doorenbos H 1980 A gonadotrophin responsive testosterone producing adrenocortical adenoma and high gonadotrophin levels in an elderly woman. Clinical Endocrinology 12 21-28.
33. LaPolt PS, Oikawa M, Jia XC, Dargan C & Hsueh AJ 1990 Gonadotropin-induced up- and down-regulation of rat ovarian LH receptor message levels during follicular growth, ovulation and luteinization. Endocrinology 126 3277-3279.
34. Larson BA, Vanderlaan WP, Judd HL & McCullough DL 1976 A testosterone-producing adrenal cortical adenoma in an elderly woman. Journal of Clinical Endocrinology and Metabolism 42 882-887.
35. Leinonen P, Ranta T, Siegberg R, Pelkonen R, Heikkila P & Kahri A 1991 Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency. Clinical Endocrinology 34 31-35.
36. Leuschner C & Hansel W 2004 Membrane disrupting lytic peptides for cancer treatments. Current Pharmaceutical Design 10 2299-2310.
37. Leuschner C, Enright FM, Melrose PA & Hansel W 2001 Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors. Prostate 46 116-125.
38. Leuschner C, Enright FM, Gawronska B & Hansel W 2003a Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo. Breast Cancer Research and Treatment 78 17-27.
39. Leuschner C, Enright FM, Gawronska-Kozak B & Hansel W 2003b Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors. Prostate 56 239-249.
40. Manna PR, El-Hefnawy T, Kero J & Huhtaniemi IT 2001 Biphasic action of prolactin in the regulation of murine Leydig tumor cell functions. Endocrinology 142 308-318.
41. Mazzuco TL, Chabre O, Feige JJ & Thomas M 2006 Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. Journal of Clinical Endocrinology and Metabolism 91 196-203.
42. Mijnhout GS, Danner SA, van de Goot FR & van Dam EW 2004 Macronodular adrenocortical hyperplasia in a postmenopausal woman. Netherlands Journal of Medicine 62 454-455.
43. Mikola M, Kero J, Nilson JH, Keri RA, Poutanen M & Huhtaniemi I 2003 High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene. Oncogene 22 3269-3278.
44. Miyamura N, Taguchi T, Murata Y, Taketa K, Iwashita S, Matsumoto K, Nishikawa T, Toyonaga T, Sakakida M & Araki E 2002 Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland. Endocrine 19 319-326.
45. Moran DS, Eli-Berchoer L, Heled Y, Mendel L, Schocina M & Horowitz M 2006 Heat intolerance: does gene transcription contribute? Journal of Applied Physiology 100 1370-1376.
46. Morrisey EE, Ip HS, Tang Z & Parmacek MS 1997 GATA-4 activates transcription via two novel domains that are conserved within the GATA-4/5/6 subfamily. Journal of Biological Chemistry 272 8515-8524.
47. Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA & Rao CV 1996 Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. Journal of Clinical Endocrinology and Metabolism 81 2397-2400.
48. Pakarainen T, Zhang FP, Poutanen M & Huhtaniemi I 2005 Fertility in luteinizing hormone receptor-knockout mice after wild-type ovary transplantation demonstrates redundancy of extragonadal luteinizing hormone action. Journal of Clinical Investigation 115 1862-1868.
49. Pakarainen T, Ahtiainen P, Zhang FP, Rulli S, Poutanen M & Huhtaniemi I 2007 Extragonadal LH/hCG action-not yet time to rewrite textbooks. Molecular and Cellular Endocrinology 269 9-16.
50. Peterson RA II, Kiupel M, Bielinska M, Kiiveri S, Heikinheimo M, Capen CC & Wilson DB 2004 Transcription factor GATA-4 is a marker of anaplasia in adrenocortical neoplasms of the domestic ferret (Mustela putorius furo). Veterinary Pathology 41 446-449.
51. Rahman NA, Kananen Rilianawati K, Paukku T, Mikola M, Markkula M, Hamalainen T & Huhtaniemi IT 1998 Transgenic mouse models for gonadal tumorigenesis. Molecular and Cellular Endocrinology 145 167-174.
52. Rahman NA, Kiiveri S, Siltanen S, Levallet J, Kero J, Lensu T, Wilson DB, Heikinheimo MT & Huhtaniemi IT 2001 Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61. Reproductive Biology 1 5-9.
53. Rahman NA, Kiiveri S, Rivero-Muller A, Levallet J, Vierre S, Kero J, Wilson DB, Heikinheimo M & Huhtaniemi I 2004 Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4. Molecular Endocrinology 18 2553-2569.
54. Rao ChV, Zhou XL & Lei ZM 2004 Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells. Biology of Reproduction 71 579-587.
55. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM & Chrousos GP 1994 p53 Mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. Journal of Clinical Endocrinology and Metabolism 78 790-794.
56. Rilianawati, Kero J, Paukku T & Huhtaniemi I 2000 Long-term testosterone treatment prevents gonadal and adrenal tumorigenesis of mice transgenic for the mouse inhibin-alpha subunit promoter/simian virus 40 T-antigen fusion gene. Journal of Endocrinology 166 77-85.
57. Rilianawati, Paukku T, Kero J, Zhang FP, Rahman N, Kananen K & Huhtaniemi I 1998 Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Molecular Endocrinology 12 801-809.
58. Risma KA, Clay CM, Nett TM, Wagner T, Yun J & Nilson JH 1995 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. PNAS 92 1322-1326.
59. Rivero-Muller A, Vuorenoja S, Tuominen M, Waclawik A, Brokken LJ, Ziecik AJ, Huhtaniemi I & Rahman NA 2007 Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors. Molecular and Cellular Endocrinology 269 17-25.
60. Saner-Amigh K, Mayhew BA, Mantero F, Schiavi F, White PC, Rao CV & Rainey WE 2006 Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. Journal of Clinical Endocrinology and Metabolism 91 1136-1142.
61. Schulick RD & Brennan MF 1999a Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Annual Surgery and Oncology 6 719-726.
62. Schulick RD & Brennan MF 1999b Adrenocortical carcinoma. World Journal of Urology 17 26-34.
63. Sheeler LR 1994 Cushing's syndrome and pregnancy. Endocrinology and Metabolism Clinics of North America 23 619-627.
64. Smith HC, Posen S, Clifton-Bligh P & Casey J 1978 A testosterone-secreting adrenal cortical adenoma. Australia and New Zealand Journal of Medicine 8 171-175.
65. Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B & Manns MP 2002 Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50 259-265.
66. Takahashi H, Yoshizaki K, Kato H, Masuda T, Matsuka G, Mimura T, Inui Y, Takeuchi S, Adachi H & Matsumoto K 1978 A gonadotrophin-responsive virilizing adrenal tumour identified as a mixed ganglioneuroma and adrenocortical adenoma. Acta Endocrinologica 89 701-709.
67. Tremblay JJ & Viger RS 1999 Transcription factor GATA-4 enhances Mullerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. Molecular Endocrinology 13 1388-1401.
68. Utsugi T, Schroit AJ, Connor J, Bucana CD & Fidler IJ 1991 Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Research 51 3062-3066.
69. Vuorenoja S, Rivero-Muller A, Kiiveri S, Bielinska M, Heikinheimo M, Wilson DB, Huhtaniemi IT & Rahman NA 2007 Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6. Molecular and Cellular Endocrinology 269 38-45.
70. Werk EE Jr, Sholiton LE & Kalejs L 1973 Testosterone-secreting adrenal adenoma under gonadotropin control. New England Journal of Medicine 289 767-770.
71. Westphal G, Burgemeister R, Friedemann G, Wellmann A, Wernert N, Wollscheid V, Becker B, Vogt T, Knuchel R, Stolz W et al. 2002 Noncontact laser catapulting: a basic procedure for functional genomics and proteomics. Methods in Enzymology 356 80-99.
72. Wy LA, Carlson HE, Kane P, Li X, Lei ZM & Rao CV 2002 Pregnancy-associated Cushing's syndrome secondary to a luteinizing hormone/human chorionic gonadotropin receptor-positive adrenal carcinoma. Gynecological Endocrinology 16 413-417.
73. Zaleska M, Waclawik A, Bodek G, Zezula-Szpyra A, Li X, Janowski T, Hansel WH, Rahman NA & Ziecik AJ 2004 Growth repression in diethylstilbestrol/ dimethylbenz[a]-anthracene-induced rat mammary gland tumor using Hecate-CGbeta conjugate. Experimental Biology and Medicine 229 335-344.
74. Zhang FP, Hämäläinen T, Kaipia A, Pakarinen P & Huhtaniemi I 1994 Ontogeny of luteinizing hormone receptor gene expression in the rat testis. Endocrinology 134 2206-2213.